Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 28:13:930756.
doi: 10.3389/fendo.2022.930756. eCollection 2022.

Myoinositol in Autoimmune Thyroiditis

Sabrina Rosaria Paparo  1 , Silvia Martina Ferrari  2 , Armando Patrizio  3 , Giusy Elia  1 , Francesca Ragusa  1 , Chiara Botrini  1 , Eugenia Balestri  1 , Fabrizio Guarneri  4 , Salvatore Benvenga  5   6   7 , Alessandro Antonelli  1 , Poupak Fallahi  8
Affiliations
Review

Myoinositol in Autoimmune Thyroiditis

Sabrina Rosaria Paparo et al. Front Endocrinol (Lausanne). .

Abstract

Myoinositol (Myo) is an isoform of inositol, a cyclic polyol with 6 hydroxyl groups. Myo is mainly derived from dietary intake while its endogenous production is generated from glucose by enzymatic reactions. Moreover, Myo is also synthesized de novo by catabolism of phosphatidylinositol (PI), phosphoinositides (PIP), and inositol phosphates (IP). Myo has a determinant role in thyroid function and autoimmune diseases as it regulates iodine organification and thyroid hormone biosynthesis by the formation of hydrogen peroxide (H2O2) in thyrocytes. Depletion of Myo that is involved in the thyroid stimulating hormone (TSH) signaling pathway, may cause the development of thyroid diseases such as hypothyroidism. TSH levels significantly decreased in patients with subclinical hypothyroidism, with or without autoimmune thyroiditis, after treatment with Myo plus Selenium (Myo+Se). In addition to TSH, antithyroid autoantibodies are reduced. This review summarizes the role of Myo in the thyroidal physiology and its role in the management of some thyroid diseases.

Keywords: CXCL10; autoimmune thyroiditis; chemokines; hypothyroidism; myoinositol.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Benvenga S, Ferrari SM, Elia G, Ragusa F, Patrizio A, Paparo SR, et al. Nutraceuticals in Thyroidology: A Review of in Vitro, and in Vivo Animal Studies. Nutrients (2020) 12:1337. doi: 10.3390/nu12051337 - DOI - PMC - PubMed
    1. Downes CP, Macphee CH. Myo-Inositol Metabolites as Cellular Signals. Eur J Biochem (1990) 193:1–18. doi: 10.1111/j.1432-1033.1990.tb19297.x - DOI - PubMed
    1. Clements RS, Jr, Darnell B. Myo-Inositol Content of Common Foods: Development of a High-Myo-Inositol Diet. Am J Clin Nutr (1980) 33:1954–67. doi: 10.1093/ajcn/33.9.1954 - DOI - PubMed
    1. Schneider S. Inositol Transport Proteins. FEBS Lett (2015) 589:1049–58. doi: 10.1016/j.febslet.2015.03.012 - DOI - PubMed
    1. Croze ML, Soulage CO. Potential Role and Therapeutic Interests of Myo-Inositol in Metabolic Diseases. Biochimie (2013) 95:1811–27. doi: 10.1016/j.biochi.2013.05.011 - DOI - PubMed

Publication types